Abu Dhabi Investment Authority (ADIA) will make an anchor commitment of $500 million to an India special situations fund launched in conjunction with Kotak Private Equity.
Philippines private equity firm Navegar has launched its second growth fund focused exclusively on its home market with a target of $150 million.
Long timeframes of incremental growth from a shallow base will test the staying power of a new generation of Australian venture capital funds. But confidence is running high
Quadrant Private Equity is planning to raise a A$300 million ($215 million) fund focused on growth equity investments in small and medium-sized enterprises in Australia.
Will the rapid increases in fund size for the likes of Japan Industrial Partners and Polaris Private Equity turn out to be the exception or the rule in Japan's middle market?
Estonian private equity firm BaltCap and the Japan Bank for International Cooperation (JBIC) have launched a EUR100 million ($113 million) Europe-Asia cross-border VC fund with a focus on Japan.
Australia’s Artesian Venture Partners and government-backed Grains Research & Development Corporation (GRDC) have launched a A$50 million ($36 million) agriculture technology VC fund.
Shenzhen Capital Group and SOSV Investments have agreed to establish a China-focused angel investment fund as well as a growth stage vehicle targeting European companies.
Driven by an existing portfolio that includes workforce management platform Deputy, Australia's EVP successfully tapped high net worth investors for its $25 million second fund
Intudo Ventures has raised $50 million for its second Indonesia-focused fund, drawing on strong support from international investors such as Founders Fund
Tata Group ethics and sustainability veteran Mukund Rajan has helped pair some former colleagues with Quantum Advisors to tackle a messy environmental, social, and governance (ESG) situation in India
Lilly Asia Ventures (LAV) has closed its fifth healthcare fund – which operates globally but primarily backs companies with a China angle – at the hard cap of $750 million. It represents a meaningful step up in size from the $450 million raised for...
Singapore’s government plans to invest S$100 million ($74 million) in Singapore-based start-ups and small and medium-sized enterprises (SMEs) in 2019, along with other measures aimed at promoting local businesses.
Having raised $250 million for its third India healthcare fund, Invascent Capital plans to take advantage of a greater willingness among entrepreneurs to work with financial investors
Australia’s Equity Venture Partners (EVP) has closed its second VC fund at A$35 million ($25 million). It will make early-stage investments in local B2B software companies.
Intudo Ventures has closed its second fund focused exclusively on Indonesian early-stage companies at $50 million. The firm raised $20 million for its debut vehicle last year.
Should you take a 3x return today or wait for a potentially larger exit next year? For GPs, this decision is complicated by fears of a downturn, the timing of future fundraises, and conflicting LP feedback
Allianz Investment Management, a unit of insurance giant Allianz Group, has invested over $200 million in a private debt platform managed by Edelweiss Alternative Asset Advisors, the alternative investment arm of India’s Edelweiss Group.
TPG Capital has closed its seventh pan-Asian fund at $4.6 billion after approximately two years in the market. The vehicle is already 40% committed across 12 companies.
Enterprise Angels, a New Zealand angel investor network that focuses on domestic IT, agriculture, food, horticulture, life science and biotech companies, has launched its third early-stage VC fund.
Indian venture capital firm 3one4 Capital has reached a first close on a INR3.5 billion ($50 million) fund with INR1.5 billion in commitments.
Ascendent Capital Partners is seeking $800 million for its third China mid-market fund. The GP closed its previous vehicle at $600 million in 2015.
Investors are looking to capitalize on the China distress opportunity, and recent activity in around non-performing loans suggests there will be enough deal flow to sate their appetites
Invascent Capital, an Indian healthcare-focused GP, has closed its third vehicle at the hard cap of $250 million.